The cost-effectiveness of the omeprazole test in patients with noncardiac chest pain.

  title={The cost-effectiveness of the omeprazole test in patients with noncardiac chest pain.},
  author={Joshua J. Ofman and Ian Mark Gralnek and Jayshree Udani and M. Brian Fennerty and Ronnie Fass},
  journal={The American journal of medicine},
  volume={107 3},
PURPOSE Recent evidence suggests that an empiric trial of omeprazole (the "omeprazole test") is sensitive and specific for diagnosing gastroesophageal reflux disease (GERD) as the cause of noncardiac chest pain. Our objective was to examine the clinical, economic, and policy implications of alternative diagnostic strategies for patients with noncardiac chest pain. METHODS Decision analysis was used to evaluate the clinical and economic outcomes of two diagnostic strategies that begin with the… CONTINUE READING

From This Paper

Topics from this paper.


Publications citing this paper.
Showing 1-10 of 23 extracted citations

Noncardiac chest pain: update on the diagnosis and management.

The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi • 2015
View 8 Excerpts
Highly Influenced

US-Based Drug Cost Parameter Estimation for Economic Evaluations.

Medical decision making : an international journal of the Society for Medical Decision Making • 2015
View 1 Excerpt

Functional disorders of the gastrointestinal tract: Cost effectiveness review.

Best practice & research. Clinical gastroenterology • 2013
View 1 Excerpt

The proton pump inhibitor test for gastroesophageal reflux disease: optimal cut-off value and duration.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver • 2010

ACG Practice Guidelines: Esophageal Reflux Testing

The American Journal of Gastroenterology • 2007

Similar Papers

Loading similar papers…